AN2 Therapeutics, Inc. - ANTX
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 22
Latest filed: Sep 16, 2026
| Form | Count |
|---|---|
| 4 | 15 |
| 8-K | 5 |
| 144 | 1 |
| SCHEDULE 13G/A | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Sep 16, 2026 | 4 | Sep 15, 2026 | 0001193125-26-393274 | View |
| Sep 11, 2026 | 4 | Sep 09, 2026 | 0001193125-26-389545 | View |
| Sep 08, 2026 | 4 | Sep 03, 2026 | 0001193125-26-385511 | View |
| Sep 04, 2026 | 4 | Sep 01, 2026 | 0001193125-26-383697 | View |
| Sep 02, 2026 | 4 | Sep 01, 2026 | 0001193125-26-380595 | View |
| Aug 19, 2026 | 4 | Aug 17, 2026 | 0001193125-26-357225 | View |
| Aug 17, 2026 | 144 | — | 0001972481-26-000263 | View |
| Aug 14, 2026 | 4 | Aug 14, 2026 | 0001193125-26-351801 | View |
| Aug 11, 2026 | 8-K | Aug 11, 2026 | 0001193125-26-344549 | View |
| Jul 10, 2026 | 4 | Jul 10, 2026 | 0001193125-26-301165 | View |
| Jul 10, 2026 | 4 | Jul 10, 2026 | 0001193125-26-301166 | View |
| Jul 10, 2026 | 4 | Jul 10, 2026 | 0001193125-26-301167 | View |
| Jul 10, 2026 | 4 | Jul 08, 2026 | 0001193125-26-301092 | View |
| Jun 09, 2026 | 8-K | Jun 03, 2026 | 0001193125-26-262264 | View |
| Jun 04, 2026 | 8-K | Jun 04, 2026 | 0001193125-26-257430 | View |
| Jun 02, 2026 | 4 | May 29, 2026 | 0001193125-26-253622 | View |
| May 15, 2026 | SCHEDULE 13G/A | — | 0002073679-26-000066 | View |
| May 11, 2026 | 8-K | May 11, 2026 | 0001193125-26-216752 | View |
| Apr 10, 2026 | 4 | Apr 10, 2026 | 0001193125-26-151626 | View |
| Apr 10, 2026 | 4 | Apr 10, 2026 | 0001193125-26-151628 | View |
| Apr 10, 2026 | 4 | Apr 10, 2026 | 0001193125-26-151632 | View |
| Apr 09, 2026 | 8-K | Apr 09, 2026 | 0001193125-26-149822 | View |